Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Oncotarget|July 5, 2016
Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stressKshama A Doshi, Rossana Trotta, Karthika Natarajan, et al.
Molecular Cancer Research : MCR|August 1, 2006
Histone deacetylase inhibitors (HDI) cause DNA damage in leukemia cells: a mechanism for leukemia-specific HDI-dependent apoptosis?Terry J Gaymes, Rose Ann Padua, Marika Pla, et al.
Leukemia Research|April 12, 2016
Histone deacetylase inhibitors decrease NHEJ both by acetylation of repair factors and trapping of PARP1 at DNA double-strand breaks in chromatinCarine Robert, Pratik K Nagaria, Nisha Pawar, et al.
Molecular Cancer Research : MCR|April 2, 2015
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasNidal Muvarak, Shannon Kelley, Carine Robert, et al.
Cancer Genetics|December 3, 2014
High frequency of rare structural chromosome abnormalities at relapse of cytogenetically normal acute myeloid leukemia with FLT3 internal tandem duplicationTheodore S Gourdin, Ying Zou, Yi Ning, et al.
Gene|March 21, 2006
Molecular cloning of Chinese hamster 1q31 chromosomal fragile site DNA that is important to mdr1 gene amplification reveals a novel gene whose expression is associated with spermatocyte and adipocyte differentiationYingjie Wei, Yen-Chiu Lin-Lee, Xinlin Yang, et al.
Molecular Cancer Research : MCR|November 25, 2011
Targeting abnormal DNA repair in therapy-resistant breast cancersLisa A Tobin, Carine Robert, Pratik Nagaria, et al.
Cancer Research|September 19, 2007
Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia?Feyruz V Rassool, Terry J Gaymes, Nader Omidvar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
An Effective Epigenetic-PARP Inhibitor Combination Therapy for Breast and Ovarian Cancers Independent of BRCA MutationsNicholas Pulliam, Fang Fang, Ali R Ozes, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2019
DNA methyltransferase inhibitors induce a BRCAness phenotype that sensitizes NSCLC to PARP inhibitor and ionizing radiationRachel Abbotts, Michael J Topper, Christopher Biondi, et al.
Pageof 5